主要收入构成
报告期:2023-12-31
主营产品构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
其他(补充) |
1.01% |
29.46 |
-21.34% |
17.17 |
41.70% |
-14.98% |
其他贸易 |
1.13% |
32.91 |
-3.19% |
26.32 |
20.03% |
-3.26% |
医药批发 |
14.89% |
433.29 |
1.45% |
404.43 |
6.66% |
2.29% |
医药生产-儿科类 |
30.97% |
901.17 |
47.83% |
202.25 |
77.56% |
-4.91% |
医药生产-妇科类 |
0.52% |
15.23 |
44.22% |
7.41 |
51.35% |
11.05% |
医药生产-精神神经类 |
3.87% |
112.57 |
-25.15% |
43.90 |
61.00% |
-5.56% |
医药生产-抗感染类 |
1.59% |
46.14 |
33.64% |
26.70 |
42.12% |
2.76% |
医药生产-内分泌系统类 |
3.42% |
99.50 |
-- |
27.34 |
72.53% |
-- |
医药生产-其他 |
5.66% |
164.78 |
5.81% |
80.21 |
51.32% |
5.77% |
医药生产-消化系统类 |
2.70% |
78.70 |
-0.91% |
21.96 |
72.10% |
-2.03% |
医药生产-心血管系统 |
26.63% |
774.75 |
-2.91% |
213.77 |
72.41% |
4.48% |
医药生产-原料药类 |
4.90% |
142.54 |
25.28% |
97.70 |
31.46% |
-8.06% |
医药生产-止痛类 |
2.71% |
78.73 |
-60.06% |
57.19 |
27.35% |
-25.38% |
总计 |
2909.77 |
行业收入构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
其他(补充) |
1.01% |
29.46 |
-21.34% |
17.17 |
41.70% |
-14.98% |
其他贸易 |
1.13% |
32.91 |
-3.19% |
26.32 |
20.03% |
-3.26% |
医药批发 |
14.89% |
433.29 |
1.45% |
404.43 |
6.66% |
2.29% |
医药生产 |
82.97% |
2414.10 |
8.76% |
778.42 |
67.76% |
1.48% |
总计 |
2909.77 |
地区收入构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
出口业务 |
0.35% |
10.13 |
18.18% |
6.08 |
39.96% |
11.53% |
东北地区 |
7.08% |
205.89 |
27.05% |
78.67 |
61.79% |
0.42% |
华北地区 |
33.34% |
970.07 |
8.95% |
600.48 |
38.10% |
0.22% |
华东地区 |
20.40% |
593.48 |
-0.05% |
187.33 |
68.44% |
9.03% |
华南地区 |
7.42% |
215.95 |
-0.92% |
43.46 |
79.87% |
14.37% |
华中地区 |
12.29% |
357.67 |
16.93% |
120.28 |
66.37% |
3.51% |
其他(补充) |
1.01% |
29.46 |
-21.34% |
17.17 |
41.70% |
-14.98% |
西北地区 |
6.73% |
195.84 |
45.67% |
88.26 |
54.93% |
-13.11% |
西南地区 |
11.39% |
331.28 |
-9.90% |
84.60 |
74.46% |
-1.47% |
总计 |
2909.77 |